Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/49/1e/7e/491e7ef8-6996-a544-5e98-e0cc06aa0149/mza_10921017996814677989.png/600x600bb.jpg
touchPODCAST
touchpodcast
517 episodes
1 week ago
Show more...
Science
RSS
All content for touchPODCAST is the property of touchpodcast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/49/1e/7e/491e7ef8-6996-a544-5e98-e0cc06aa0149/mza_10921017996814677989.png/600x600bb.jpg
Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages
touchPODCAST
32 minutes
1 month ago
Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages
touchEXPERT FOCUS for touchONCOLOGYListen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.The expert: Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchONCOLOGY.com
touchPODCAST